BSEBoard Meeting6d ago · 6 Aug 2026, 07:10 pm
Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve and take on record the ....
Brooks Laboratories Ltd · 533543
✦ AI SummaryResults
Brooks Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/08/2026 to consider and approve the Unaudited standalone and consolidated financial results for the quarter ended 30th June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Brooks Laboratories Ltd - 533543 - Board Meeting Intimation for Under Regulation 29 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 (''''SEBI Listing Regulations'''')
Attachments (1)
📄pdf
Download →
15a7fdb8-d122-413d-9c81-b68b9772b10e.pdf
View document text
Corp. Off.:- 201, “The Summit Business Bay”
Behind Guru Nanak Petrol Pump,
Off Andheri Kurla Road, Andheri (E),
Mumbai - 400 093 (India)
Ph. : +91 22 69073100
6th August 2026
BSE Limited National Stock Exchange of India Ltd.
Listing Department Listing Department
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai-400001 Bandra (E), Mumbai-400051
Scrip Code: 533543 Symbol: BROOKS
Sub: Intimation under Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements)
Regulations, 2015.
Dear Sir/ Madam,
Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we hereby inform that the meeting of the Board of Directors of Brooks Laboratories Limited is scheduled
to be held on Thursday, 13th August 2026, inter alia to consider and approve the Unaudited standalone
and consolidated financial results for the quarter ended 30th June 2026 alongwith Limited Review Report
of the Statutory Auditors of the Company thereon.
Further, referring to our communication dated 23rd June 2026, and pursuant to SEBI (Prohibition of Insider
Trading) Regulations, 2015 and Company’s Code of Conduct for Prevention of Insider Trading, the trading
window for all Directors and Designated Persons and their immediate relatives and specified Connected
Persons has been kept closed for dealing in the securities of the Company w.e.f. 1st July 2026. This is to
further inform that the trading window will be re-opened for the aforesaid persons after Forty Eight (48)
hours after the declaration of Unaudited Financial Results to deal in the securities of the Company.
Kindly take the same on record.
Thanking You,
Yours faithfully
For BROOKS LABORATORIES LIMITED
Krutika Rane
Company Secretary and Compliance Officer
Membership no. 66310
Regd. Off & Works : Village Kishanpura, Baddi Nalagarh Road, Baddi (H.P.) - 174101 (India) Tele Fax .: 01795 236939
(CIN NO: L24232HP2002PLC000267), E-mail : investors@brookslabs.net, Website: www.brookslabs.net